Edoxaban vs Rituximab

Edoxaban vs Rituximab: Overview

This comparison examines the pharmacological differences between Edoxaban and Rituximab.

Mechanism of Action

Edoxaban: Direct, selective inhibitor of Factor Xa preventing thrombin generation and clot formation.

Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

Pharmacokinetics

Half-life: Edoxaban — 10-14 hours; Rituximab — 22 days.

Chemical Properties

Molecular Formula: Edoxaban — C24H30ClN7O4S.

Molecular Weight: Edoxaban — 548.0530 g/mol.

Type: Edoxaban — Small molecule; Rituximab — Antibody.